Potent antitumor activity of an auristatin-conjugated, fully human monoclonal antibody to prostate-specific membrane antigen

D Ma, CE Hopf, AD Malewicz, GP Donovan… - Clinical Cancer …, 2006 - AACR
Prostate-specific membrane antigen (PSMA) is the prototypic cell-surface marker of prostate
cancer and provides an attractive target for monoclonal antibody (mAb) targeted therapies …
被引用次数：170 相关文章

Potent antitumor activity of an auristatin-conjugated, fully human monoclonal antibody to prostate-specific membrane antigen

D Ma, CE Hopf, AD Malewicz… - … : an official journal …, 2006 - pubmed.ncbi.nlm.nih.gov
Prostate-specific membrane antigen (PSMA) is the prototypic cell-surface marker of prostate
cancer and provides an attractive target for monoclonal antibody (mAb) targeted therapies …

[引用][C] Potent antitumor activity of an auristatin-conjugated, fully human monoclonal antibody to prostate-specific membrane antigen

D MA, CE HOPF, AD MALEWICZ… - Clinical cancer …, 2006 - pascal-francis.inist.fr
Potent antitumor activity of an auristatin-conjugated, fully human monoclonal antibody to
prostate-specific membrane antigen CNRS Inist Pascal-Francis CNRS Pascal and Francis …

Potent antitumor activity of an auristatin-conjugated, fully human monoclonal antibody to prostate-specific membrane antigen.

D Ma, CE Hopf, AD Malewicz, GP Donovan… - … Cancer Research: an …, 2006 - europepmc.org
Prostate-specific membrane antigen (PSMA) is the prototypic cell-surface marker of prostate
cancer and provides an attractive target for monoclonal antibody (mAb) targeted therapies …

[引用][C] Potent antitumor activity of an auristatin-conjugated, fully human monoclonal antibody to prostate-specific membrane antigen

D MA, CE HOPF… - Clinical …, 2006 - American Association for Cancer …